NCT06181097 Routine Use of Negative Pressure Wound Therapy THR TKR RCT
| NCT ID | NCT06181097 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Knee Arthropathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 82 participants |
| Start Date | 2023-12-11 |
| Primary Completion | 2025-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 82 participants in total. It began in 2023-12-11 with a primary completion date of 2025-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Negative pressure wound therapy (NPWT) for post total joint arthroplasty incisions has demonstrated benefits in reducing wound complications. A prospective randomized trial will be conducted including 40 patients who will undergo total knee and total hip arthroplasty. The number of wound complications within 21 days will be recorded. As well, the aesthetic appearance and quality of scarring of the scar will be assessed.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing total knee or total hip arthroplasty at Prince of Wales Hospital, Hong Kong. Exclusion Criteria: * Patients using steroid, or other immune modulators that is known to affect wound healing, prior surgery to the knee or hip, skin condition such as eczema that would result in poor healing or widen scars, patients with a known significant history of hypertrophic scarring or keloid.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06181097 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Knee Arthropathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06181097 currently recruiting?
Yes, NCT06181097 is actively recruiting participants. Contact the research team at michael.ong@cuhk.edu.hk for enrollment information.
Where is the NCT06181097 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06181097 clinical trial?
NCT06181097 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 82 participants.